Search research articles
Contact Us
Filters
Showing results (81-90 of 99) with videos related to
Page
of 10
Sort By:
The Journal of Clinical Investigation
|
September 8, 2020
Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation
Gunjan L Shah, Susan DeWolf, Yeon Joo Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 27, 2016
Ex Vivo CD34<sup>+</sup>-Selected T Cell-Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is Associated with Low Incidence of Acute and Chronic Graft-versus-Host Disease and High Treatment Response
Pere Barba, Patrick Hilden, Sean M Devlin, et al.
The Lancet. Haematology
|
December 3, 2025
Model-based antithymocyte globulin dosing in ex vivo CD34+ selected allogeneic haematopoietic cell transplantation: a single-centre, single-arm, phase 2 study
Michael Scordo, Miguel-Angel Perales, Audrey Mauguen, et al.
The Lancet. Haematology
|
February 26, 2021
Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registry
Roni Shouval, Joshua A Fein, Myriam Labopin, et al.
The Journal of Clinical Investigation
|
March 23, 2023
Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant
Susan E Prockop, Aisha Hasan, Ekaterina Doubrovina, et al.
Blood Advances
|
December 8, 2020
High progression-free survival after intermediate intensity double unit cord blood transplantation in adults
Juliet N Barker, Sean M Devlin, Kristine A Naputo, et al.
Transplantation and Cellular Therapy
|
May 25, 2021
Relapse after Allogeneic Stem Cell Transplantation of Acute Myelogenous Leukemia and Myelodysplastic Syndrome and the Importance of Second Cellular Therapy
Corrado Zuanelli Brambilla, Stephanie M Lobaugh, Josel D Ruiz, et al.
Leukemia & Lymphoma
|
September 3, 2021
Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant
Jan Philipp Bewersdorf, Andriy Derkach, Lohith Gowda, et al.
Blood Advances
|
June 12, 2025
Bone marrow and blood demonstrate distinct immune reconstitution patterns and correlations with relapse post-transplant
Susan DeWolf, Jason Kuttiyara, Paola Vinci, et al.
Journal of Palliative Medicine
|
March 29, 2020
Characteristics and Impact of Post-Transplant Interdisciplinary Palliative Care Consultation in Older Allogeneic Hematopoietic Cell Transplant Recipients
Richard J Lin, Abigail G Cohen, Stacy M Stabler, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 99) with videos related to
Sort By:
Page
of 10
The Journal of Clinical Investigation
|
September 8, 2020
Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation
Gunjan L Shah, Susan DeWolf, Yeon Joo Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 27, 2016
Ex Vivo CD34<sup>+</sup>-Selected T Cell-Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is Associated with Low Incidence of Acute and Chronic Graft-versus-Host Disease and High Treatment Response
Pere Barba, Patrick Hilden, Sean M Devlin, et al.
The Lancet. Haematology
|
December 3, 2025
Model-based antithymocyte globulin dosing in ex vivo CD34+ selected allogeneic haematopoietic cell transplantation: a single-centre, single-arm, phase 2 study
Michael Scordo, Miguel-Angel Perales, Audrey Mauguen, et al.
The Lancet. Haematology
|
February 26, 2021
Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registry
Roni Shouval, Joshua A Fein, Myriam Labopin, et al.
The Journal of Clinical Investigation
|
March 23, 2023
Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant
Susan E Prockop, Aisha Hasan, Ekaterina Doubrovina, et al.
Blood Advances
|
December 8, 2020
High progression-free survival after intermediate intensity double unit cord blood transplantation in adults
Juliet N Barker, Sean M Devlin, Kristine A Naputo, et al.
Transplantation and Cellular Therapy
|
May 25, 2021
Relapse after Allogeneic Stem Cell Transplantation of Acute Myelogenous Leukemia and Myelodysplastic Syndrome and the Importance of Second Cellular Therapy
Corrado Zuanelli Brambilla, Stephanie M Lobaugh, Josel D Ruiz, et al.
Leukemia & Lymphoma
|
September 3, 2021
Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant
Jan Philipp Bewersdorf, Andriy Derkach, Lohith Gowda, et al.
Blood Advances
|
June 12, 2025
Bone marrow and blood demonstrate distinct immune reconstitution patterns and correlations with relapse post-transplant
Susan DeWolf, Jason Kuttiyara, Paola Vinci, et al.
Journal of Palliative Medicine
|
March 29, 2020
Characteristics and Impact of Post-Transplant Interdisciplinary Palliative Care Consultation in Older Allogeneic Hematopoietic Cell Transplant Recipients
Richard J Lin, Abigail G Cohen, Stacy M Stabler, et al.
Page
of 10